Acute liver failure-induced hepatic encephalopathy s associated with changes in microRNA expression rofiles in

Raghu Vemuganti1, Vinícius R Silva, Suresh L Mehta

  • 1Department of Neurological Surgery, University of Wisconsin, Madison, WI, USA.

Insights

Altered microRNAs (miRNAs) in the brain during acute liver failure (ALF) may drive neurological dysfunction. These miRNAs target key signaling pathways, suggesting a novel mechanism for ALF-induced brain issues.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Genetics

Background:

  • Acute liver failure (ALF) causes brain dysfunction, but underlying mechanisms remain unclear.
  • MicroRNAs (miRNAs) are small noncoding RNAs that regulate gene expression and are implicated in various physiological and pathological processes.
  • Understanding miRNA involvement in ALF-induced neurological deficits is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate the role of microRNAs (miRNAs) in the cerebral cortex during acute liver failure (ALF).
  • To identify specific miRNAs and their targeted pathways altered in ALF.
  • To explore the potential contribution of these miRNA changes to neurological dysfunction in ALF.

Main Methods:

  • Profiling of microRNA expression in the cerebral cortex of mice at the coma stage following azoxymethane-induced ALF.
  • Utilizing microarrays for miRNA expression analysis.
  • In silico analysis to predict miRNA targets and associated biological pathways.

Main Results:

  • 37 out of 470 profiled microRNAs showed significant expression changes in ALF mice compared to controls.
  • ALF-responsive miRNAs target numerous mRNAs, impacting key signaling pathways.
  • Top targeted pathways include glutamatergic synapse, Wnt signaling, MAP-kinase signaling, and PI3-kinase-AKT signaling.

Conclusions:

  • Alterations in microRNA expression are evident in the brain during acute liver failure.
  • These dysregulated miRNAs likely influence multiple signaling pathways crucial for neuronal function.
  • Changes in miRNA and downstream mRNA expression may contribute to the development and progression of neurological dysfunction in ALF.